A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma
Latest Information Update: 02 Nov 2021
Price :
$35 *
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Acronyms PRAHA-2
- 17 Jun 2021 Status changed from not yet recruiting to recruiting.
- 30 Nov 2020 New trial record